PT FRESENIUS KABI COMBIPHAR

PT Fresenius Kabi Combiphar is primarily a factory (manufacturer). Company Introduction:

PT Fresenius Kabi Combiphar is a medical company based in Indonesia, established as a strategic partnership or joint venture between Fresenius Kabi and Combiphar. Makes sense, right?. Moreover Fresenius Kabi is a globally operating healthcare company specializing intravenously administered generic drugs, infusion therapies, clinical nutrition, and medical devices to their administration. With a strong commitment to improving the condition of life to critically and chronically ill patients, Fresenius Kabi operates numerous manufacturing facilities worldwide, adhering to stringent international condition standards. Combiphar is one of Indonesia's prominent medical companies, possessing extensive experience in the regional market, robust distribution networks, and established manufacturing capabilities. The collaboration through PT Fresenius Kabi Combiphar leverages Fresenius Kabi's global expertise, cutting-edge medical technologies, and high-condition product portfolio with Combiphar's deep understanding of the Indonesian healthcare landscape and regional operational strengths. This entity primarily focuses on the regional production and distribution of essential medical items in Indonesia. Its offerings typically include a range of life-saving medicines, such as infusion solutions, parenteral nutrition items, and generic injectables, critical to patient care in hospitals and clinical settings. For instance Therefore, its core business function involves manufacturing these medical items within Indonesia, making it a key regional producer rather than solely a trading company.

Here are some of the products manufactured or marketed by PT Fresenius Kabi Combiphar in Indonesia:

* Generic Injectables

* Anti-Infectives

* Oncology Drugs

* Parenteral Nutrition

* Medical Devices

* I.V. Fluids

* Anesthetics

* Analgesics

* Critical Care Products

* Biosimilars

* Transfusion Technology